Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of AImmune Technology as a Bioinformatic Component of Diagnostic Tests Used in Cancer Immunotherapy

NCT04145232 is registered in ClinicalTrials.gov with Ardigen as lead sponsor.

NCT NCT04145232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04145232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of AImmune Technology as a Bioinformatic Component of Diagnostic Tests Used in Cancer Immunotherapy
Lead sponsor
Ardigen
Phase
Observational
Overall status
Unknown status
Start date
June 13, 2019
Completion date
November 30, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy, neoantigens, neoepitopes, next generation sequencing (ngs), non small cell lung cancer, personalized neoantigen cancer vaccine